- Home
- MDAI vs ASBP Comparison
MDAI vs ASBP Comparison
Compare MDAI & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- ASBP
- Stock Information
- Founded
- MDAI 2013
- ASBP 2021
- Country
- MDAI United States
- ASBP United States
- Employees
- MDAI N/A
- ASBP N/A
- Industry
- MDAI Medical/Dental Instruments
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- MDAI Health Care
- ASBP Health Care
- Exchange
- MDAI Nasdaq
- ASBP Nasdaq
- Market Cap
- MDAI 27.8M
- ASBP 26.6M
- IPO Year
- MDAI N/A
- ASBP N/A
- Fundamental
- Price
- MDAI $1.29
- ASBP $0.61
- Analyst Decision
- MDAI Strong Buy
- ASBP
- Analyst Count
- MDAI 2
- ASBP 0
- Target Price
- MDAI $4.75
- ASBP N/A
- AVG Volume (30 Days)
- MDAI 426.7K
- ASBP 1.1M
- Earning Date
- MDAI 05-06-2025
- ASBP 05-24-2025
- Dividend Yield
- MDAI N/A
- ASBP N/A
- EPS Growth
- MDAI N/A
- ASBP N/A
- EPS
- MDAI N/A
- ASBP N/A
- Revenue
- MDAI $29,581,000.00
- ASBP N/A
- Revenue This Year
- MDAI N/A
- ASBP N/A
- Revenue Next Year
- MDAI $49.47
- ASBP N/A
- P/E Ratio
- MDAI N/A
- ASBP N/A
- Revenue Growth
- MDAI 63.83
- ASBP N/A
- 52 Week Low
- MDAI $0.82
- ASBP $0.52
- 52 Week High
- MDAI $3.25
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- MDAI 39.65
- ASBP N/A
- Support Level
- MDAI $1.04
- ASBP N/A
- Resistance Level
- MDAI $1.76
- ASBP N/A
- Average True Range (ATR)
- MDAI 0.16
- ASBP 0.00
- MACD
- MDAI -0.02
- ASBP 0.00
- Stochastic Oscillator
- MDAI 31.65
- ASBP 0.00
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract.